Recently, we investigated canonical and non-canonical components of TGF-β signaling pathway and demonstrated the poor survival imparted by TGF-β signaling and PAI-1, in patients with ccRCC [25]. Here, TGFB1 is linked to nonpapillary renal cell carcinoma.